A therapeutic strategy for human hepatocellular carcinoma using "armed" oncolytic herpes simplex viruses.
A therapeutic strategy for human hepatocellular carcinoma using "armed" oncolytic herpes simplex viruses.
批准号:
17K18252
负责人:
NAKATAKE Richi
金额:
$2.83万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2017
资助国家:
日本
项目状态:
已结题
起止时间:
2017-04-01 至 2019-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Curcumin protects liver inflammation by suppressing iNOS induction in rat hepatocytes
姜黄素通过抑制大鼠肝细胞 iNOS 诱导来保护肝脏炎症
DOI:
--
发表时间:
2017
期刊:
影响因子:
--
作者:
[Nakatake R, Hishikawa H, Matushima H, Nakamura Y, Ishizaki M, Matsui K, Kaibori M, Nishizawa M, Okumura T, AH-Kwon.]
通讯作者:
AH-Kwon.
Case report: resection for primary retroperitoneal serous adenocarcinoma and liver metastasis
病例报告:原发性腹膜后浆液性腺癌并肝转移的切除术
DOI:
--
发表时间:
2018
期刊:
Intern Med
影响因子:
--
作者:
[Nakatake R, Ishizaki M, Ishida M, Matui K, Kawaguchi Y, Kaibori M]
通讯作者:
Kaibori M
Metformin has a protective effect through the inhibition of inducible nitric oxide synthase gene expression in hepatocytes
二甲双胍通过抑制肝细胞中诱导型一氧化氮合酶基因表达发挥保护作用
DOI:
--
发表时间:
2018
期刊:
影响因子:
--
作者:
[Nakatake R, Iida H, Ishizaki M, Matsui K, Nakamura Y, Kaibori M, Nishizawa M, Okumura T]
通讯作者:
Okumura T
DOI:
10.1371/journal.pone.0183527
发表时间:
2017
期刊:
PloS one
影响因子:
3.7
作者:
[Tsuda T, Kaibori M, Hishikawa H, Nakatake R, Okumura T, Ozeki E, Hara I, Morimoto Y, Yoshii K, Kon M]
通讯作者:
Kon M
Metformin inhibits expression of the proinflammatory biomarker inducible nitric oxide synthase in hepatocytes.
二甲双胍抑制肝细胞中促炎生物标志物诱导型一氧化氮合酶的表达。
DOI:
--
发表时间:
2018
期刊:
Functional Foods in Health and Disease
影响因子:
1
作者:
[Nakatake R, Iida H, Ishizaki M, Matsui K, Nakamura Y, Kaibori M, Nishizawa M, Okumura T.]
通讯作者:
Okumura T.
共 12 条
Development of a new sense oligonucleotide drug targeting inducible nitric oxide synthase for sepsis model rats
-
批准号:19K18370
-
项目类别:Grant-in-Aid for Early-Career Scientists
-
资助金额:$2.66万
-
财政年份:2019
-
负责人:NAKATAKE Richi
-
依托单位: